COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.

Lin, Chung M A; Bennett, Josh; Rajagopala, Lavanya; Hunter, Ewan; Lorenzi, Alice R; Griffiths, Bridget; Baker, Kenneth F

Lin, Chung M A; Bennett, Josh; Rajagopala, Lavanya; Hunter, Ewan; Lorenzi, Alice R; Griffiths, Bridget; Baker, Kenneth F.

Afiliación

Lin CMA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Bennett J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Rajagopala L; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Hunter E; Department of Infectious Diseases, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Lorenzi AR; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Griffiths B; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Baker KF; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Rheumatology (Oxford) ; 62(6): e185-e187, 2023 06 01.

Article en En | MEDLINE | ID: mdl-36534829

Asunto(s)

Antirreumáticos; COVID-19; Enfermedades Reumáticas; Humanos; Enfermedades Reumáticas/tratamiento farmacológico; Antirreumáticos/uso terapéutico; Antivirales/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Antirreumáticos / COVID-19 Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google